Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:artemether
gptkb:lumefantrine |
| gptkbp:alternativeName |
gptkb:Coartem
|
| gptkbp:approvedBy |
gptkb:US_Food_and_Drug_Administration
gptkb:European_Medicines_Agency 1999 |
| gptkbp:ATCCode |
gptkb:P01BF01
|
| gptkbp:combinationTherapy |
true
|
| gptkbp:contraindication |
hypersensitivity to artemether or lumefantrine
|
| gptkbp:drugClass |
antimalarial
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Riamet
|
| gptkbp:indication |
treatment of uncomplicated Plasmodium falciparum malaria
|
| gptkbp:marketedAs |
gptkb:Novartis
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
anorexia
dizziness headache QT prolongation Sleep disorder palpitations |
| gptkbp:usedFor |
malaria
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:artemether
|
| gptkbp:bfsLayer |
6
|